Commercialization risk
Revenue depends on convincing researchers and labs to adopt a new proteomics platform.
- Scope
- Platinum instruments, consumables, and software
- Materiality
- high
Quantum-Si Inc
Quantum-Si Inc. is a U.S.-based life sciences instrumentation company focused on proteomics research through its Next-Gen Protein Sequencing platform. The company develops and commercializes the Platinum instrument family, consumables, software workflows, and related services for research laboratories and other scientific users.
−4 583,1 %
47,3 %
−4 160,1 %
−20,3 %
7.64
7.50
| % | |
|---|---|
| Instruments | 45% Benchtop proteomics sequencing instruments sold under the Platinum line, including Platinum Pro. |
| Consumables | 40% Library prep kits, barcoding kits, sequencing kits, reagents, chips, and related disposables. |
| Software and workflows | 5% Analysis software and computational workflows used to interpret proteomic data. |
| Services | 10% Maintenance contracts, advanced training, and customer support services. |
Quantum-Si sells to scientific users that need protein analysis tools for research and applied workflows...
- Academic researchprimary
Universities and research institutes buy instruments and kits to study proteins and validate proteomics methods.
- Biopharmaprimary
Drug discovery and development teams use the platform for protein characterization and translational research.
- CDMOssecondary
Contract development and manufacturing organizations use the system for quality control testing and applied workflows.
- Government and industrialsecondary
Public-sector and industrial labs buy systems for research, assay development, and specialized protein analysis.
Quantum-Si is headquartered in the United States and sells directly there, while Europe is served through a mix of...
- •United States is the core direct-sales market
- •Europe uses a combined direct and distributor model
- •Distributor partners extend reach into EMEA, APAC, and South America
- •Western Europe is a stated commercial focus
- •Geographic partner network supports international adoption
Quantum-Si is focused on commercializing its proteomics platform by expanding sales coverage, generating scientific...
01
Commercialize the Platinum platformshort-term
Instrument placement and consumable pull-through are central to building a recurring proteomics business.
02
Expand product roadmapmedium-term
New instruments, kits, and software increase application breadth and customer retention.
03
Build scientific validationmedium-term
Proteomics adoption depends on published evidence and KOL support for the platform's utility.
04
Protect intellectual propertylong-term
Patent coverage helps defend the platform and reduce fast-follower risk.
Quantum-Si faces the typical risks of an early-stage life sciences tools company: adoption uncertainty, limited...
Funding and liquidity risk
The company has historically negative cash flow and may need debt or equity financing to support operations.
- Scope
- R&D, inventory build, sales expansion
- Materiality
- high
Intellectual property risk
The platform relies on patents and licensed IP; loss of protection could weaken differentiation.
- Scope
- Proteomics detection platform and related workflows
- Materiality
- high
Limited operating history
The company has not yet established a long track record of scaled commercialization.
- Scope
- Forecasting, customer adoption, channel buildout
- Materiality
- high
Partner/channel execution risk
International growth depends partly on distributors and third-party sales partners.
- Scope
- Europe, Middle East, Africa, APAC, South America
- Materiality
- medium
AI and machine learning compliance risk
Use of AI/ML in internal functions may create regulatory and legal exposure.
- Scope
- General and administrative and R&D processes
- Materiality
- low
Revenue recognition by product and service type
Reported revenue mix and timing
Inventory valuation and write-offs
Cost of revenue and gross profit
Warranty and service obligations
Operating expenses and cost of revenue
Royalty and licensed IP payments
Cost structure and liquidity
Fair value estimates for investments
Balance sheet and other income/expense
Quanterix Corp
QTRX · Laboratory Analytical Instruments
Quanterix Corp develops and commercializes ultra-sensitive life science instruments, assay kits, and related services used to measure proteins and biomarkers in biological samples.
Quantum Computing Inc.
QUBT · Services-Prepackaged Software
QUANTUM CORP /DE/
QMCO · Computer Storage Devices
Quantum Corp is a U.S.-based storage technology company that designs, manufactures, and sells primary storage, secondary storage, and data management solutions.
Quantum Genesis AI Corp.
QTZM · Industrial Organic Chemicals
Qnity Electronics, Inc.
Q · Semiconductors & Related Devices
Seer, Inc.
SEER · Laboratory Analytical Instruments
: 29/04/2026